DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) – Equities research analysts at Barrington Research lowered their Q1 2022 earnings estimates for shares of DENTSPLY SIRONA in a report issued on Wednesday, April 20th. Barrington Research analyst M. Petusky now anticipates that the medical instruments supplier will post earnings per share of $0.49 for the quarter, down from their prior estimate of $0.65. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q2 2022 earnings at $0.58 EPS, Q3 2022 earnings at $0.66 EPS and Q4 2022 earnings at $0.72 EPS.
A number of other equities research analysts have also recently commented on the company. Bank of America cut DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $66.00 to $49.00 in a research note on Tuesday. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $62.00 to $52.00 and set an “overweight” rating for the company in a research note on Wednesday. TheStreet lowered shares of DENTSPLY SIRONA from a “b-” rating to a “c+” rating in a report on Friday, March 18th. Robert W. Baird downgraded DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and cut their price target for the company from $67.00 to $48.00 in a research note on Tuesday. Finally, The Goldman Sachs Group lowered their price objective on DENTSPLY SIRONA from $59.00 to $47.00 and set a “neutral” rating for the company in a research note on Thursday. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Hold” and an average price target of $53.11.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its quarterly earnings results on Monday, February 28th. The medical instruments supplier reported $0.76 earnings per share for the quarter, missing the consensus estimate of $0.79 by ($0.03). The company had revenue of $1.09 billion during the quarter, compared to the consensus estimate of $1.13 billion. DENTSPLY SIRONA had a net margin of 9.90% and a return on equity of 12.51%. The company’s revenue for the quarter was up .6% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share.
Institutional investors and hedge funds have recently modified their holdings of the stock. First Trust Advisors LP grew its stake in DENTSPLY SIRONA by 203.9% in the 1st quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock valued at $4,517,000 after purchasing an additional 61,111 shares during the period. Amundi Pioneer Asset Management Inc. grew its position in DENTSPLY SIRONA by 39.9% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock valued at $9,157,000 after buying an additional 52,645 shares during the period. Morgan Stanley increased its holdings in DENTSPLY SIRONA by 16.1% during the second quarter. Morgan Stanley now owns 607,754 shares of the medical instruments supplier’s stock worth $38,445,000 after buying an additional 84,088 shares during the last quarter. WINTON GROUP Ltd bought a new stake in DENTSPLY SIRONA in the third quarter worth about $416,000. Finally, Signaturefd LLC boosted its stake in DENTSPLY SIRONA by 92.1% in the third quarter. Signaturefd LLC now owns 1,581 shares of the medical instruments supplier’s stock valued at $92,000 after acquiring an additional 758 shares during the last quarter. 97.32% of the stock is owned by institutional investors.
The firm also recently announced a quarterly dividend, which was paid on Friday, April 8th. Stockholders of record on Friday, March 25th were issued a $0.125 dividend. The ex-dividend date of this dividend was Thursday, March 24th. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a dividend yield of 1.19%. DENTSPLY SIRONA’s dividend payout ratio is currently 26.04%.
DENTSPLY SIRONA Company Profile (Get Rating)
DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.
- Get a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)
- MarketBeat Podcast: 3 Stocks Flashing Buy Signals
- Should You Buy Carvana or AutoNation or Pass on Both?
- What Should Investors Take Away From Boston Beer’s Earnings?
- High-Yield Kinder Morgan Is Still A Buy
- NextEra Energy Offers a Long-Term Gain if You Can Tolerate Short-Term Pain
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.